title: Vaccination against tumour blood vessels in colorectal cancer.
authors.affiliation: School of Immunity and Infection and Cancer Studies, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Department of Colorectal Surgery, Queen Elizabeth Hospital, Mindelsohn Way, Birmingham B15 2TH, UK. Electronic address: fergusonh@doctors.org.uk.
authors.forename: H J M
authors.initials: HJ
authors.lastname: Ferguson
authors.affiliation: School of Immunity and Infection and Cancer Studies, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: JWW162@bham.ac.uk.
authors.forename: J
authors.initials: J
authors.lastname: Wragg
authors.affiliation: Department of Colorectal Surgery, Queen Elizabeth Hospital, Mindelsohn Way, Birmingham B15 2TH, UK. Electronic address: tariq.ismail@uhb.nhs.uk.
authors.forename: T
authors.initials: T
authors.lastname: Ismail
authors.affiliation: School of Immunity and Infection and Cancer Studies, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: r.bicknell@bham.ac.uk.
authors.forename: R
authors.initials: R
authors.lastname: Bicknell
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D019496:Cancer Vaccines / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000628:therapy*; D006801:Humans; D061206:Neoplasm Micrometastasis / Q000628:therapy*; D000077544:Panitumumab; D018074:Vaccines, Conjugate; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D018074:Vaccines, Conjugate; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000077544:Panitumumab; D000068818:Cetuximab